drugset / Trial / NCT04222699

Cultures Before and After Decolonization in Community Dwelling Adults With Current S. Aureus Colonization

NCT04222699

Phase 4 Completed 58 enrolled VA Office of Research and Development
NaSingle-groupOpen-labelHealth-services research

Summary

The investigators propose to study the microbiome of the nose, throat and three skin sites in a population without current exposure to the healthcare environment: 80 community dwelling adults. We will characterize the microbial communities in these body sites (nose, throat, perirectal and three skin sites) over time using culture-independent techniques. The investigators will then "decolonize" the subjects. Subjects will receive intranasal mupirocin and topical chlorhexidine. The investigators will then compare the microbial communities at baseline and after decolonization within individuals. Our overall hypothesis is that the microbial composition of these sites and the response to decolonization is influenced by the healthcare environment and that decolonization leads to re-colonization with an increasing proportion of Gram-negative bacilli.

Timeline

Start
2012-09-18
Primary completion
2014-11-18
Completion
2014-11-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorhexidine Small molecule 4 % Topical
Subject Mupirocin Small molecule 2 % Intranasal

Indications

No indication recorded.